|
2009 Journal Article c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-κB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individualsSourris, Karly C., Lyons, Jasmine G., de Courten, Maximilian P. J., Dougherty, Sonia L., Henstridge, Darren C., Cooper, Mark E., Hage, Michelle, Dart, Anthony, Kingwell, Bronwyn A., Forbes, Josephine M. and de Courten, Barbora (2009). c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-κB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes, 58 (6), 1259-1265. doi: 10.2337/db08-1725 |
|
2009 Journal Article High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitusDrew, Brian G., Duffy, Stephen J., Formosa, Melissa F., Natoli, Alaina K., Henstridge, Darren C., Penfold, Sally A., Thomas, Walter G., Mukhamedova, Nigora, de Courten, Barbora, Forbes, Josephine M., Yap, Felicia Y., Kaye, David M., van Hall, Gerrit, Febbraio, Mark A., Kemp, Bruce E., Sviridov, Dmitri, Steinberg, Gregory R. and Kingwell, Bronwyn A. (2009). High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation, 119 (15), 2103-2111. doi: 10.1161/CIRCULATIONAHA.108.843219 |
|
2009 Journal Article The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled studyKoska, J., Ortega, E., Bunt, J. C., Gasser, A., Impson, J., Hanson, R. L., Forbes, J., de Courten, B. and Krakoff, J. (2009). The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia, 52 (3), 385-393. doi: 10.1007/s00125-008-1239-x |
|
2009 Journal Article Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic TargetsSourris, Karly C. and Forbes, Josephine M. (2009). Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic Targets. Current Drug Targets, 10 (1), 42-50. doi: 10.2174/138945009787122905 |
|
2009 Journal Article A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: Common downstream endpoints achieved through disparate therapeutic approaches?Sourris, Karly C., Harcourt, Brooke E. and Forbes, Josephine M. (2009). A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: Common downstream endpoints achieved through disparate therapeutic approaches?. American Journal of Nephrology, 30 (4), 323-335. doi: 10.1159/000226586 |
|
2009 Journal Article Rage-induced cytosolic ROS promote mitochondrial superoxide generation in diabetesCoughlan, Melinda T., Thorburn, David R., Penfold, Sally A., Laskowski, Adrienne, Harcourt, Brooke E., Sourris, Karly C., Tan, Adeline L. Y., Fukami, Kei, Thallas-Bonke, Vicki, Nawroth, Peter P., Brownlee, Michael, Bierhaus, Angelika, Cooper, Mark E. and Forbes, Josephine M. (2009). Rage-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. Journal of the American Society of Nephrology, 20 (4), 742-752. doi: 10.1681/ASN.2008050514 |
|
2008 Journal Article Heat shock protein expression in diabetic nephropathyBarutta, Federica, Pinach, Silvia, Giunti, Sara, Vittone, Ferdinando, Forbes, Josephine M., Chiarle, Roberto, Arnstein, Maryann, Perin, Paolo Cavallo, Camussi, Giovanni, Cooper, Mark E. and Gruden, Gabriella (2008). Heat shock protein expression in diabetic nephropathy. American Journal of Physiology - Renal Physiology, 295 (6), F1817-F1824. doi: 10.1152/ajprenal.90234.2008 |
|
2008 Journal Article Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetesSoro-Paavonen, Aino, Watson, Anna M. D., Li, Jiaze, Paavonen, Karri, Koitka, Audrey, Calkin, Anna C., Barit, David, Coughlan, Melinda T., Drew, Brian G., Lancaster, Graeme I., Thomas, Merlin, Forbes, Josephine M., Nawroth, Peter P., Bierhaus, Angelika, Cooper, Mark E. and Jandeleit-Dahm, Karin A. (2008). Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes, 57 (9), 2461-2469. doi: 10.2337/db07-1808 |
|
2008 Journal Article Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEsTikellis, Christos, Thomas, Merlin C., Harcourt, Brooke E., Coughlan, Melinda T., Pete, Josepha, Bialkowski, Katarzyna, Tan, Adeline, Bierhaus, Angelika, Cooper, Mark E. and Forbes, Josephine M. (2008). Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. American Journal of Physiology: Endocrinology and Metabolism, 295 (2), E323-E330. doi: 10.1152/ajpendo.00024.2008 |
|
2008 Journal Article Response to comment on: Thallas-bonke et al. (2008) inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway:Diabetes 57:460-469, 2008Thallas-Bonke, Vicki and Forbes, Josephine M. (2008). Response to comment on: Thallas-bonke et al. (2008) inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway:Diabetes 57:460-469, 2008. Diabetes, 57 (6), e14-e14. doi: 10.2337/db08-0406 |
|
2008 Journal Article Oxidative stress as a major culprit in kidney disease in diabetesForbes, Josephine M., Coughlan, Melinda T. and Cooper, Mark E. (2008). Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes, 57 (6), 1446-1454. doi: 10.2337/db08-0057 |
|
2008 Journal Article MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin modelFukuda, Kyoichi, Tesch, Greg H., Yap, Felicia Y., Forbes, Josephine M., Flavell, Richard A., Davis, Roger J. and Nikolic-Paterson, David J. (2008). MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin model. Laboratory Investigation, 88 (4), 398-407. doi: 10.1038/labinvest.2008.10 |
|
2008 Journal Article Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathwayThallas-Bonke, Vicki, Thorpe, Suzanne R., Coughlan, Melinda T., Fukami, Kei, Yap, Felicia Y. T., Sourris, Karly C., Penfold, Sally A., Bach, Leon A., Cooper, Mark E. and Forbes, Josephine M. (2008). Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-α-dependent pathway. Diabetes, 57 (2), 460-469. doi: 10.2337/db07-1119 |
|
2008 Journal Article Advanced glycation: implications in tissue damage and diseaseGasser, Anna and Forbes, Josephine M. (2008). Advanced glycation: implications in tissue damage and disease. Protein and Peptide Letters, 15 (4), 385-391. doi: 10.2174/092986608784246515 |
|
2007 Journal Article Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic propertiesHoang, A., Murphy, A. J., Coughlan, M. T., Thomas, M. C., Forbes, J. M., O'Brien, R., Cooper, M. E., Chin-Dusting, J. P. F. and Sviridov, D. (2007). Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties. Diabetologia, 50 (8), 1770-1779. doi: 10.1007/s00125-007-0718-9 |
|
2007 Journal Article Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Coughlan, Melinda T., Thallas-Bonke, Vicki, Pete, Josefa, Long, David M., Gasser, Anna, Tong, David C. K., Arnstein, Maryann, Thorpe, Suzanne R., Cooper, Mark E. and Forbes, Josephine M. (2007). Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?. Endocrinology, 148 (2), 886-895. doi: 10.1210/en.2006-1300 |
|
2007 Journal Article AGE, RAGE, and ROS in diabetic nephropathyTon, Adeline L. Y., Forbes, Josephine M. and Cooper, Mark E. (2007). AGE, RAGE, and ROS in diabetic nephropathy. Seminars in Nephrology, 27 (2), 130-143. doi: 10.1016/j.semnephrol.2007.01.006 |
|
2007 Journal Article Renal microvascular injury in diabetes: RAGE and redox signalingCoughlan, Melinda T., Cooper, Mark E. and Forbes, Josephine M. (2007). Renal microvascular injury in diabetes: RAGE and redox signaling. Antioxidants and Redox Signaling, 9 (3), 331-342. doi: 10.1089/ars.2006.1469 |
|
2007 Journal Article Diabetic nephropathy: where hemodynamics meets metabolismForbes, J. M., Fukami, K. and Cooper, M. E. (2007). Diabetic nephropathy: where hemodynamics meets metabolism. Experimental and Clinical Endocrinology and Diabetes, 115 (2), 69-84. doi: 10.1055/s-2007-949721 |
|
2006 Journal Article Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal diseaseBurns, Wendy C., Twigg, Stephen M., Forbes, Josephine M., Pete, Josefa, Tikellis, Christos, Thallas-Bonke, Vicki, Thomas, Merlin C., Cooper, Mark E. and Kantharidis, Phillip (2006). Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. Journal of the American Society of Nephrology, 17 (9), 2484-2494. doi: 10.1681/ASN.2006050525 |
